Joe Diaz | Lytham Partners |
Ronan O’Caoimh | Chairman and Chief Executive Officer |
John Gillard | Chief Financial Officer and Director |
Jim Sidoti | Sidoti & Co |
Paul Nouri | Noble Equity Funds |
Good morning, everyone. And welcome to the Trinity Biotech Q2 2021 Financial Results Conference Call. All participants will be in a listen-only mode. [Operator Instructions] Please also note today's event is being recorded. At this time, I would like to turn the conference call over to Joe Diaz with Lytham Partners.